Abstract
Cell death is a major component of developmental programs. Controlled killing of specific cells at appropriate time points is required for normal growth and shaping of organisms. However, cellular demolition can also result in a variety of pathologies that are frequently fatal, when implemented inappropriately. Delineation of cell death mechanisms has been greatly facilitated by the use of simple model organisms such as the nematode worm Caenorhabditis elegans. Research in C. elegans has proven instrumental for the elucidation of the molecular mechanisms underlying both apoptotic and necrotic cell death. Here, we introduce the C. elegans model and review the current understanding of cell death pathways in this organism. We further focus on recent studies implicating autophagy, the main cellular process for bulk protein and organelle recycling, in nematode cell death. These studies reveal that autophagic mechanisms have a prominent role in both apoptosis and necrosis. We survey the relevant findings in C. elegans and also consider the contribution of autophagy in cell death in other experimental systems. Comparative analysis suggests that the involvement of autophagy in cell death is evolutionary conserved in metazoans. Thus, interfering with the autophagic process may facilitate therapeutic intervention in human pathologies where aberrant cell death is a contributing factor.
Keywords: Apoptosis, Autophagy, Beclin, Caenorhabditis elegans, Excitotoxicity, Lysosome, Necrosis, Neurodegeneration
Current Pharmaceutical Design
Title: Autophagy and Cell Death in Caenorhabditis elegans
Volume: 14 Issue: 2
Author(s): Nektarios Tavernarakis and Chrysanthi Samara
Affiliation:
Keywords: Apoptosis, Autophagy, Beclin, Caenorhabditis elegans, Excitotoxicity, Lysosome, Necrosis, Neurodegeneration
Abstract: Cell death is a major component of developmental programs. Controlled killing of specific cells at appropriate time points is required for normal growth and shaping of organisms. However, cellular demolition can also result in a variety of pathologies that are frequently fatal, when implemented inappropriately. Delineation of cell death mechanisms has been greatly facilitated by the use of simple model organisms such as the nematode worm Caenorhabditis elegans. Research in C. elegans has proven instrumental for the elucidation of the molecular mechanisms underlying both apoptotic and necrotic cell death. Here, we introduce the C. elegans model and review the current understanding of cell death pathways in this organism. We further focus on recent studies implicating autophagy, the main cellular process for bulk protein and organelle recycling, in nematode cell death. These studies reveal that autophagic mechanisms have a prominent role in both apoptosis and necrosis. We survey the relevant findings in C. elegans and also consider the contribution of autophagy in cell death in other experimental systems. Comparative analysis suggests that the involvement of autophagy in cell death is evolutionary conserved in metazoans. Thus, interfering with the autophagic process may facilitate therapeutic intervention in human pathologies where aberrant cell death is a contributing factor.
Export Options
About this article
Cite this article as:
Tavernarakis Nektarios and Samara Chrysanthi, Autophagy and Cell Death in Caenorhabditis elegans, Current Pharmaceutical Design 2008; 14 (2) . https://dx.doi.org/10.2174/138161208783378770
DOI https://dx.doi.org/10.2174/138161208783378770 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Application of Endothelial Progenitor Cells for Treatment of Cardiovascular Diseases
Current Stem Cell Research & Therapy Patent Selections:
Recent Patents on Drug Delivery & Formulation Lost in Translation: What is Limiting Cardiomyoplasty and Can Tissue Engineering Help?
Current Stem Cell Research & Therapy Side Effects of Clozapine and Some Other Psychoactive Drugs
Current Drug Safety Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses
Current Pharmaceutical Design Role of Autophagy in Alzheimer’s Disease
Current Enzyme Inhibition An Insight of Novel Pharmacological Therapies in Hypertrophic Cardiomyopathy
Medicinal Chemistry Selectivity Problems with Drugs Acting on Cardiac Na<sup>+</sup> and Ca<sup>2+</sup> Channels
Current Medicinal Chemistry Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part B))
Current Pharmaceutical Design Future Perspectives in the Pharmacological Treatment of Atrial Fibrillation and Ventricular Arrhythmias in Heart Failure
Current Pharmaceutical Design Diabetic Retinopathy and Atherosclerosis: is there a Link?
Current Diabetes Reviews Current Drug Nano-targeting Strategies for Improvement in the Diagnosis and Treatment of Prevalent Pathologies such as Cardiovascular and Renal Diseases
Current Drug Targets Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors
Current Cancer Drug Targets Lipoproteins, Stroke and Statins
Current Vascular Pharmacology Decoding the Transcriptional Response to Ischemic Stroke in Obese and Non-obese Mice Brain
Current Neurovascular Research Methods to Evaluate the Inhibition of TTR Fibrillogenesis Induced by Small Ligands
Current Medicinal Chemistry Viral Infection - A Cure for Type 1 Diabetes?
Current Medicinal Chemistry A Glance on the Role of Bacterial Siderophore from the Perspectives of Medical and Biotechnological Approaches
Current Drug Targets Target-based Anti-angiogenic Therapy in Breast Cancer
Current Pharmaceutical Design Therapeutic Effects of Renal Denervation on Renal Failure
Current Neurovascular Research